Procurement description
NHS National Generics Pharmaceuticals - Supply Chain Resilience
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.
Periods of call-offs under the framework agreement:
CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products
CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months)
NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months)
LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months)
CM/PHG/25/5739/02 – Hospital Only Products
DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months)
DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months)
DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months)
Contract dates (estimated)
01 September 2026, 00:00AM to 31 May 2028, 23:59PM
Extension end date (if all the extensions are used): 31 August 2030